Veracity Capital LLC Increases Holdings in Avantor, Inc. (NYSE:AVTR)

Veracity Capital LLC boosted its position in shares of Avantor, Inc. (NYSE:AVTR) by 48.8% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 53,214 shares of the company’s stock after purchasing an additional 17,458 shares during the quarter. Avantor comprises about 0.5% of Veracity Capital LLC’s portfolio, making the stock its 29th biggest position. Veracity Capital LLC’s holdings in Avantor were worth $1,361,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of AVTR. Mariner LLC raised its holdings in Avantor by 17.3% in the third quarter. Mariner LLC now owns 42,025 shares of the company’s stock worth $886,000 after purchasing an additional 6,196 shares in the last quarter. Tower Research Capital LLC TRC increased its holdings in shares of Avantor by 170.4% during the third quarter. Tower Research Capital LLC TRC now owns 24,722 shares of the company’s stock valued at $521,000 after acquiring an additional 15,580 shares in the last quarter. Bank of Nova Scotia increased its holdings in shares of Avantor by 18.1% during the third quarter. Bank of Nova Scotia now owns 16,024 shares of the company’s stock valued at $338,000 after acquiring an additional 2,455 shares in the last quarter. Glenmede Trust Co. NA increased its holdings in shares of Avantor by 300.1% during the third quarter. Glenmede Trust Co. NA now owns 139,143 shares of the company’s stock valued at $2,933,000 after acquiring an additional 104,362 shares in the last quarter. Finally, Adage Capital Partners GP L.L.C. acquired a new position in shares of Avantor during the third quarter valued at about $16,864,000. 95.08% of the stock is owned by institutional investors.

Avantor Stock Performance

Avantor stock traded up $0.43 during mid-day trading on Thursday, hitting $21.01. The company had a trading volume of 5,206,885 shares, compared to its average volume of 6,874,203. The company has a current ratio of 1.61, a quick ratio of 1.05 and a debt-to-equity ratio of 0.94. Avantor, Inc. has a 12-month low of $16.63 and a 12-month high of $26.16. The company’s fifty day moving average is $23.47 and its 200-day moving average is $23.77. The company has a market capitalization of $14.27 billion, a price-to-earnings ratio of 53.87, a P/E/G ratio of 2.09 and a beta of 1.32.

Avantor (NYSE:AVTR) last released its quarterly earnings data on Friday, April 26th. The company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.20 by $0.02. Avantor had a return on equity of 13.01% and a net margin of 3.79%. The business had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same quarter in the prior year, the firm posted $0.29 EPS. The business’s quarterly revenue was down 5.6% compared to the same quarter last year. Equities research analysts predict that Avantor, Inc. will post 1.01 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the stock. Evercore ISI cut their price objective on shares of Avantor from $28.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Avantor from $23.00 to $25.00 and gave the company a “hold” rating in a report on Thursday, April 18th. Robert W. Baird cut their price objective on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a report on Monday, April 29th. Finally, Barclays cut their price objective on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a report on Friday, June 28th. Four research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $26.29.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.